The AHA today submitted comments to the Centers for Medicare & Medicaid Services on the agency's proposed notice of benefit and payment parameters for the 2019 health insurance marketplaces. "While we appreciate CMS's efforts to reduce regulatory burden within the health care system and provide states with increased flexibility, we are concerned that several of the proposals in the rule would reduce patient access to care, including some that could result in health plans that cover fewer benefits and expose patients to greater cost sharing," wrote AHA Executive Vice President Tom Nickels. Specifically, AHA urged CMS to abandon a proposal providing states with more flexibility on setting the essential health benefits package. "Patients would face higher out-of-pocket costs for services no longer covered, which also would not be subject to cost-sharing limits or prohibitions on annual or lifetime limits," AHA said. In addition, AHA expressed concerns with proposals related to network adequacy standards and essential community providers; medical loss ratio; and the navigator program. AHA expressed support for proposals related to special enrollment periods and minimal essential coverage designation for Children's Health Insurance Program buy-in programs. 

Headline
The Centers for Medicare & Medicaid Services will cancel approximately 315,000 enrollments impacting more than 760,000 individuals as part of its anti-…
Headline
The Workgroup for Electronic Data Interchange has launched its fall 2026 survey to assess industry readiness for the Centers for Medicare & Medicaid…
Blog
To reduce suicide in the healthcare workforce, hospitals and health systems must create an environment where workers feel safe asking for help.By Susan…
Headline
The departments of Health and Human Services, Labor, and the Treasury have added Physio Solutions, LLC as a new independent dispute resolution entity…
Headline
The Department of Health and Human Services announced Sept. 8 through the Substance Abuse and Mental Health Services Administration that it will award $383.4…
Headline
The Trump administration announced Aug. 31 agreements with nine additional pharmaceutical manufacturers aimed at lowering prescription drug prices through a…